Strategic Project Management for Accelerated Drug Development
Expert project leadership to keep complex programs on track, aligned, and moving forward—so you can…
Certara2025 年 12 月 23 日
A Systematic Review and Model-Based Meta-Analysis of Pegylated-Interferon-α-Induced HBsAg Loss in Chronic Hepatitis B Virus Infection
This study synthesizes data from a large body of clinical trials to evaluate rates of…
Certara2025 年 12 月 18 日
Merck Advances Pediatric Oncology with Innovative ADC Modeling
Merck leveraged ADC modeling and pediatric ADC dose optimization to enable FDA acceptance and advance…
Certara2025 年 12 月 12 日
Expedited Pharmacometrics Regulatory Submissions
Certara delivers complete, compliant pharmacometric regulatory submission packages in just 4–6 weeks, eliminating the PMx…
Certara2025 年 12 月 8 日
Certara Cuts Pharmacometrics Submission Timelines in Half: New Expedited Service Accelerates Global Regulatory Filings
Certara launches an expedited Pharmacometrics (PMx) Regulatory Submission service that cuts submission timelines in half.
Certara2025 年 12 月 3 日
Supporting KalVista’s NDA Submission for a Novel HAE Treatment
To accelerate the first oral therapy for hereditary angioedema (HAE), KalVista Pharmaceuticals partnered with Certara…
Danielle Pillsbury2025 年 11 月 12 日
Quantitative Model-Informed Dose Selection for a Milvexian Phase III Study in Patients With Atrial Fibrillation
This study demonstrates how model-informed approaches can improve dose selection decisions when direct clinical comparisons…
Certara2025 年 11 月 5 日
Delivering on Deadline: Navigating Regulatory Submissions with Pharmacometrics Insights
Watch this on-demand webinar to learn how pharmacometrics supports NDA, BLA, and global regulatory submissions.…
Certara2025 年 11 月 3 日
